kras mutation and glutathion KRAS-Mutant Lung Cancer: Targeting Molecular Immunologic Pathways, Therapeutic Advantages and Restrictions Uncovering new therapeutic targets for
Uncovering new therapeutic targets for a common KRAS mutation behind cancer KRAS mutation shown to promote tumor evasion of innate immune surveillance in lung cancer Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell Frontiers Targeting KRAS: The Elephant in the Room of Epithelial Cancers KRAS OriGene Technologies Inc.
Pay in 4 interest-free payments of $5.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13




